Cystic fibrosis year in review 2019: Section 1 CFTR modulators-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cystic fibrosis year in review 2019: Section 1 CFTR modulators

Published:2020-09 Issue:12 Volume:55 Page:3236-3242
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Savant Adrienne P.¹²^ORCID,McColley Susanna A.³⁴⁵^ORCID

Affiliation:

1. Children's Hospital of New Orleans New Orleans Louisiana

2. Department of Pediatrics, Division of Pulmonary Medicine Tulane University School of Medicine New Orleans Illinois

3. Department of Pediatrics, Feinberg School of Medicine Northwestern University Chicago Illinois

4. Stanley Manne Children's Research Institute Chicago Illinois

5. Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25039

Reference36 articles.

1. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

2. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

3. The suppression of premature termination codons and the repair of splicing mutations in CFTR

4. Functional Properties of Mixed Cystic Fibrosis and Normal Bronchial Epithelial Cell Cultures

5. Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities;Scientific Reports;2023-09-12

2. Cystic fibrosis: Infection prevention & control recommendations for universities, colleges and institutes of further and higher education – A practical guide;Infection, Disease & Health;2023-05

3. Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk;Molecular Diagnosis & Therapy;2023-03-20

4. Sexual and reproductive health experiences and care of adult women with cystic fibrosis;Journal of Cystic Fibrosis;2023-03

5. Menopause in people with cystic fibrosis;Menopause;2023-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3